NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/20/2022
Back to search
Official data from USPTO
LINC-IG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
LINC-IG
ST13
US500000090805833Class
5, 42, 45
Filing
90805833
Registration
6927711
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
12/20/2022
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 45
Filing date
07/01/2021
Registration date
12/20/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2022
Last transaction
12/20/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
HARDY LUDLOW, TARAH
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. K. (pessoa física)
Representatives
Bassam N. Ibrahim BUCHANAN INGERSOLL & ROONEY, PC
Technical classification
Nice Classes
Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human usepharmaceutical antibodies or its fragments or its derivativescells and genes that produce antibodiesfragments of antibodies or derivatives of antibodies for use in the treatment or prevention of infectious and parasitic diseasescancerblood and blood-forming organs diseases and disorders involving the immune mechanismendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eye and adnexadiseases of the ear and mastoid processdiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary systempregnancychildbirth and the puerperiumcongenital malformationsdeformations and chromosomal abnormalitiesfor medical and pharmaceutical use
Class 42
Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
Class 45
Granting of licenses to others for the use of industrial property rights and copyright
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/20/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/14/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/14/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/28/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/28/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/02/2022
PUBO
PUBLISHED FOR OPPOSITION
08/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2022
ALIE
ASSIGNED TO LIE
06/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/10/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/28/2022
GNRT
NON-FINAL ACTION E-MAILED
03/28/2022
CNRT
NON-FINAL ACTION WRITTEN
03/28/2022
DOCK
ASSIGNED TO EXAMINER
03/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2021
NWAP
NEW APPLICATION ENTERED
07/05/2021
Continuous trademark protection
Get notified about every new filing that threatens LINC-IG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.